Abstract
Interleukin (IL)-12 is a pivotal cytokine that strongly stimulates Th1-associated cellular immunity. It is now recognized that IL-12 also activates humoral immunity to both T-dependent and T-independent antigens. This has let to considerable interest in exploiting IL-12 as a vaccine adjuvant for protection against various bacterial and viral pathogens, particularly in the lung. Studies examining the efficacy of IL-12-mediated effects on protective antibody response in the mouse model are summarized in this review.
Copyright 2010 Elsevier Ltd. All rights reserved.
Publication types
-
Research Support, N.I.H., Extramural
-
Review
MeSH terms
-
Adjuvants, Immunologic / pharmacology*
-
Animals
-
Antibody Formation / drug effects*
-
Antibody Formation / immunology
-
Bacterial Infections / immunology
-
Bacterial Infections / prevention & control
-
Bacterial Vaccines / immunology
-
Bacterial Vaccines / pharmacology*
-
Humans
-
Immunity, Cellular / drug effects
-
Immunity, Cellular / immunology
-
Interleukin-12 / pharmacology*
-
Mice
-
Th1 Cells / immunology
-
Viral Vaccines / immunology
-
Viral Vaccines / pharmacology*
-
Virus Diseases / immunology
-
Virus Diseases / prevention & control
Substances
-
Adjuvants, Immunologic
-
Bacterial Vaccines
-
Viral Vaccines
-
Interleukin-12